歐盟評(píng)估刺柏油和刺柏酊劑作為所有動(dòng)物飼料添加劑的安全性和有效性
(資料圖)
2023年4月20日,據(jù)歐盟食品安全局(EFSA)消息,應(yīng)歐盟委員會(huì)要求,歐盟動(dòng)物飼料添加劑和產(chǎn)品(FEEDAP)研究小組就刺柏油和刺柏酊劑(juniper oil and juniper tincture)作為所有動(dòng)物飼料添加劑的安全性和有效性發(fā)表科學(xué)意見。經(jīng)過評(píng)估,專家小組認(rèn)為刺柏酊劑在動(dòng)物飼料中最大建議使用量45%以下是安全的,對消費(fèi)者和環(huán)境也是安全的。由于刺柏的果實(shí)及其制劑可以給食物調(diào)味,并且它們在飼料中的功能是相同的,因此認(rèn)為沒有必要證明其功效。部分原文報(bào)道如下:
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of juniper oil and juniper tincture obtained from the berries of Juniperus communis L., when used as sensory additives for all animal species. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that juniper oil is safe up to the maximum proposed use levels in complete feed of 5 mg/kg for laying hens, 15 mg/kg for veal calves (milk replacer) and cattle for fattening and 20 mg/kg for ornamental fish. For the other species, the calculated safe concentrations in complete feed were 4 mg/kg for chickens for fattening, 5 mg/kg for turkeys for fattening, 7 mg/kg for piglets, 8 mg/kg for pigs for fattening, 10 mg/kg for sows, dairy cows, 16 mg/kg for sheep, goats and horses, 6 mg/kg for rabbits, 17 mg/kg for salmonids, 18 mg/kg for dogs and 3 mg/kg for cats. These conclusions were extrapolated to other physiologically related species. For any other species, the additive was considered safe at 3 mg/kg complete feed. The FEEDAP Panel concluded that juniper tincture is safe up to the maximum proposed use level in feed of 45 mg/kg complete feed or water for drinking for all animal species. No concerns for consumers and the environment were identified following the use of the additives to the highest safe level in feed. The additives under assessment should be considered as irritants to skin and eyes, and as skin and respiratory sensitisers. Since the berries of J. communis and their preparations are recognised to flavour food and their function in feed would be the same as that in food, no further demonstration of efficacy was considered necessary.
編輯:qysb005標(biāo)簽: